Ondine Biomedical Inc. (LON:OBI – Get Free Report) hit a new 52-week low during mid-day trading on Thursday . The company traded as low as GBX 5.50 ($0.07) and last traded at GBX 5.88 ($0.07), with a volume of 431829 shares trading hands. The stock had previously closed at GBX 6.25 ($0.08).
Ondine Biomedical Stock Performance
The company has a debt-to-equity ratio of 24.39, a quick ratio of 8.26 and a current ratio of 2.34. The company has a market capitalization of £13.32 million, a PE ratio of -99.08 and a beta of -0.14. The business’s 50-day moving average is GBX 8.76 and its 200-day moving average is GBX 9.32.
About Ondine Biomedical
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
Further Reading
- Five stocks we like better than Ondine Biomedical
- Are Penny Stocks a Good Fit for Your Portfolio?
- MarketBeat Week in Review – 4/22 – 4/26
- Why is the Ex-Dividend Date Significant to Investors?
- 3 Stocks Leading the U.S. Agriculture Comeback
- 3 REITs to Buy and Hold for the Long Term
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
